AAAAAA
Results:
1-13
|
Results: 13
Authors:
Roller, RE
Renner, W
Dorr, A
Pilger, E
Schnedl, WJ
Citation: Re. Roller et al., Oxidative stress and increase of vascular endothelial growth factor in plasma of patients with peripheral arterial occlusive disease, THROMB HAEM, 85(2), 2001, pp. 368-368
Authors:
Cunningham, CC
Holmlund, JT
Geary, RS
Kwoh, TJ
Dorr, A
Johnston, JF
Monia, B
Nemunaitis, J
Citation: Cc. Cunningham et al., A phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma, CANCER, 92(5), 2001, pp. 1265-1271
Authors:
Cunningham, CC
Holmlund, JT
Schiller, JH
Geary, RS
Kwoh, TJ
Dorr, A
Nemunaitis, J
Citation: Cc. Cunningham et al., A phase I trial of c-raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer, CLIN CANC R, 6(5), 2000, pp. 1626-1631
Authors:
Roller, RE
Obernosterer, A
Dorr, A
Schnedl, WJ
Citation: Re. Roller et al., No association of TGF-beta 1 antigen with the development of restenosis inpatients undergoing peripheral angioplasty, THROMB HAEM, 84(3), 2000, pp. 518-519
Authors:
Massarella, JW
He, GZ
Dorr, A
Nieforth, K
Ward, P
Brown, A
Citation: Jw. Massarella et al., The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers, J CLIN PHAR, 40(8), 2000, pp. 836-843
Authors:
Florenzano, R
Altuzarra, R
Carvajal, C
Weil, K
Dorr, A
Fullerton, C
Gottlieb, B
Baeza, H
Ramirez, L
Barcos, P
Cerda, X
Donoso, R
Citation: R. Florenzano et al., Improving the quality of interviewing teaching to medical students. An evaluation, REV MED CHI, 128(3), 2000, pp. 294-300
Authors:
Yuen, AR
Halsey, J
Fisher, GA
Holmlund, JT
Geary, RS
Kwoh, TJ
Dorr, A
Sikic, BI
Citation: Ar. Yuen et al., Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer, CLIN CANC R, 5(11), 1999, pp. 3357-3363
Authors:
Nemunaitis, J
Holmlund, JT
Kraynak, M
Richards, D
Bruce, J
Ognoskie, N
Kwoh, TJ
Geary, R
Dorr, A
Von Hoff, D
Eckhard, SG
Citation: J. Nemunaitis et al., Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer, J CL ONCOL, 17(11), 1999, pp. 3586-3595
Authors:
Holub, Z
Bartos, P
Dorr, A
Eim, J
Jabor, A
Kliment, L
Citation: Z. Holub et al., The role of laparoscopic hysterectomy and lymph node dissection in treatment of endometrial cancer, EUR J GYN O, 20(4), 1999, pp. 268-271
Authors:
Jung, D
AbdelHameed, MH
Hunter, J
Teitelbaum, P
Dorr, A
Griffy, K
Citation: D. Jung et al., The pharmacokinetics and safety profile of oral ganciclovir in combinationwith trimethoprim in HIV- and CMV-seropositive patients, BR J CL PH, 47(3), 1999, pp. 255-259
Authors:
Jung, D
Dorr, A
Citation: D. Jung et A. Dorr, Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects, J CLIN PHAR, 39(8), 1999, pp. 800-804
Authors:
Jung, D
AbdelHameed, MH
Teitelbaum, P
Dorr, A
Griffy, K
Citation: D. Jung et al., The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients, J CLIN PHAR, 39(5), 1999, pp. 505-512
Authors:
Jung, D
Griffy, K
Dorr, A
Citation: D. Jung et al., Effect of food on high-dose oral ganciclovir disposition in HIV-positive subjects, J CLIN PHAR, 39(2), 1999, pp. 161-165
Risultati:
1-13
|